Literature DB >> 2430433

Comparative prevalence of Babesia microti and Borrelia burgdorferi in four populations of Ixodes dammini in eastern Massachusetts.

J Piesman, T N Mather, J G Donahue, J Levine, J D Campbell, S J Karakashian, A Spielman.   

Abstract

We determined the prevalence of Babesia microti and Borrelia burgdorferi in four populations of Ixodes dammini in eastern Massachusetts. The Feulgen's reaction was more sensitive than the Giemsa method for detecting salivarian Babesia. A combination of darkfield and direct-fluorescent-antibody examination proved more sensitive than either method alone for detecting spirochetal infection. The prevalence of spirochetes was greater than the prevalence of Babesia in each of the tick populations studied. Overall, 24% of nymphs and 47% of adults examined were infected with spirochetes; in contrast, 11% of nymphs and 14% of adults were infected with Babesia. The difference between the spirochetal and babesial prevalence was greatest in the most recently infested site. The rising incidence of Lyme disease, as compared to the stable incidence of human babesiosis, may result from the relatively greater abundance of Bo. burgdorferi infected I. dammini ticks in newly infested locations.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2430433

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  19 in total

1.  Elimination of Borrelia burgdorferi and Anaplasma phagocytophilum in rodent reservoirs and Ixodes scapularis ticks using a doxycycline hyclate-laden bait.

Authors:  Marc C Dolan; Terry L Schulze; Robert A Jordan; Gabrielle Dietrich; Christopher J Schulze; Andrias Hojgaard; Amy J Ullmann; Cherilyn Sackal; Nordin S Zeidner; Joseph Piesman
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

2.  Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle.

Authors:  S R Telford; J E Dawson; P Katavolos; C K Warner; C P Kolbert; D H Persing
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  Invasion of two tick-borne diseases across New England: harnessing human surveillance data to capture underlying ecological invasion processes.

Authors:  Katharine S Walter; Kim M Pepin; Colleen T Webb; Holly D Gaff; Peter J Krause; Virginia E Pitzer; Maria A Diuk-Wasser
Journal:  Proc Biol Sci       Date:  2016-06-15       Impact factor: 5.349

Review 4.  Transmission of Lyme disease spirochetes (Borrelia burgdorferi).

Authors:  J Piesman
Journal:  Exp Appl Acarol       Date:  1989-06       Impact factor: 2.132

5.  Isolation of Borrelia burgdorferi from saliva of the tick vector, Ixodes scapularis.

Authors:  C Ewing; A Scorpio; D R Nelson; T N Mather
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

6.  Investigation of the validity of species status of Ixodes dammini (Acari: Ixodidae) using rDNA.

Authors:  D M Wesson; D K McLain; J H Oliver; J Piesman; F H Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

7.  An OspA antigen-capture enzyme-linked immunosorbent assay for detecting North American isolates of Borrelia burgdorferi in larval and nymphal Ixodes dammini.

Authors:  T R Burkot; R A Wirtz; B Luft; J Piesman
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

8.  Differential spirochetal infectivities to vector ticks of mice chronically infected by the agent of Lyme disease.

Authors:  C M Shih; L P Liu; A Spielman
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

9.  Stage-associated risk of transmission of the Lyme disease spirochete by European Ixodes ticks.

Authors:  F R Matuschka; P Fischer; M Heiler; S Blümcke; A Spielman
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

10.  Effect of ambient temperature on competence of deer ticks as hosts for Lyme disease spirochetes.

Authors:  C M Shih; S R Telford; A Spielman
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.